Anti-counterfeiting system also promotes flu shot

A point-of-dispensing authentication system has been used in Belgium to improve influenza vaccination rates. When pharmacists scanned drug purchases by such high-risk patients as diabetics, the system would not only check for product authenticity but also prompt the pharmacist to ask if the patient had received a flu shot. Between September and December 2009, some 300,000 messages were triggered, yielding 100,000 bookings. Article

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.